A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy

Abstract Background Recently, relugolix, an oral gonadotropin-releasing hormone receptor antagonist, has been considered an effective therapy for leiomyoma based on a phase 3 study in Japanese women. Leiomyoma combined with severe adenomyosis occasionally occurs in perimenopausal women; however, lit...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yukifumi Sasamori, Kohei Takehara, Tsuyoshi Terashima, Takako Onodera, Keita Yatsuki, Ippei Nakagawa, Yuko Takahashi, Haruka Nishida, Takayuki Ichinose, Haruko Hiraike, Kazunori Nagasaka
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2021-08-01
Sarja:	BMC Women's Health
Aiheet:	Leiomyoma Adenomyosis GnRH antagonist Relugolix Kamishoyosan
Linkit:	https://doi.org/10.1186/s12905-021-01442-x
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!